Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
A repeated dose study via the oral route (OECD 422, GLP) with wistar rats is currently ongoing. Furthermore a Repeated Dose 90-day oral toxicity study in rodents according to OECD 408 is proposed.
A 2 week preliminary oral toxicity dose range finding study has already been performed. Based on the results of this study, it can be concluded that dose levels up to 1000 mg/kg/day can be chosen for a subsequent reproductive toxicity study.
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Link to relevant study records
- Endpoint:
- short-term repeated dose toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- other information
- Study period:
- February 2021
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Remarks:
- dose finding test study
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- 14-day dose-range-finding study with daily intake concentrations of 0, 300, 1000 mg/kg bw of the test substance. The test substance was administered orally by gavage at a dose volume of 4 mL/kg bw. Control animals were dosed with the vehicle alone (corn oil).
- GLP compliance:
- not specified
- Limit test:
- no
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Batch number of test material: 0022865630
- BASF compound no.: 12/0076-2
- Retest date: 27 May 2021
- The determination of the identity, strength, purity, composition and stability of the test item was the responsibility of the Sponsor.
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: Ambient temperature
- Stability and homogeneity of the test material in the vehicle/solvent under test conditions (e.g. in the exposure medium) and during storage: The analytical method was qualified in the present study in the range from 75 to 250mg/mL. Samples of the preparations prepared in Week 1 were analysed to check the homogeneity
and concentration. The results of the analysis were within the acceptance limit for concentration and homogeneity.
TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- the test item was dissolved/suspended in the vehicle to reach required concentrations
- preparations were made daily
- concentrations were calculated and expressed in terms of test item as supplied
FORM AS APPLIED IN THE TEST (if different from that of starting material)
- in the vehicle: corn oil
OTHER SPECIFICS
- Appearance: Clear yellowish liquid - Species:
- rat
- Strain:
- other: Wistar Hannover
- Details on species / strain selection:
- The Wistar Hannover rat was the species and strain of choice because it is accepted by many regulatory authorities and there are ample experience and background data on this species and strain.
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Envigo RMS srl, San Pietro al Natisone (UD), Italy.
- Females (if applicable) nulliparous and non-pregnant: no data
- Age at study initiation: 9-10 weeks
- Weight at study initiation: 200-225 g for males and 175-200 g for females
- Fasting period before study: no data
- Housing: 5 animals of one sex per cage, in clear polysulfone solid bottomed cages
- Diet (e.g. ad libitum): laboratory rodent diet (4 RF 21, Mucedola S.r.l., Via G. Galilei, 4, 20019, SettimoMilanese (MI), Italy), ad libitum
- Water (e.g. ad libitum): water bottles, ad libitum
- Acclimation period: 6 weeks
DETAILS OF FOOD AND WATER QUALITY:
There was no information available to indicate that any non-nutrient substance likely to influence the effect of the test item was present in the drinking water or the diet.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 °C±2 °C
- Humidity (%): 55%±15 %
- Air changes (per hr): 15-20
- Photoperiod: 12 hrs dark / 12 hrs light
IN-LIFE DATES: From: 09 February 2021 To: 26 February 2021 - Route of administration:
- oral: gavage
- Details on route of administration:
- The oral route was selected as it is a possible route of exposure of the test item in man and has been specifically requested by the Regulatory Authorities.
- Vehicle:
- corn oil
- Details on oral exposure:
- PREPARATION OF DOSING SOLUTIONS:
DIET PREPARATION
- Rate of preparation of diet (frequency): Daily
VEHICLE
- The vehicle was corn oil. - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Analysis was performed in order to validate the analytical method, the preparation procedure and to verify the stability of the preparations. Samples of the preparations prepared in week 1 were analysed to check the homogeneity (in the case of suspension) and concentration.
Results were within the limit of the acceptance. - Duration of treatment / exposure:
- 14 days
- Frequency of treatment:
- daily
- Dose / conc.:
- 0 mg/kg bw/day (nominal)
- Remarks:
- control
- Dose / conc.:
- 300 mg/kg bw/day (nominal)
- Remarks:
- low dose
- Dose / conc.:
- 1 000 mg/kg bw/day (nominal)
- Remarks:
- high dose
- No. of animals per sex per dose:
- 4
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale: Dose levels have been selected in consultation with the Sponsor (dose range finding study)
- The rats were allocated to the 3 groups by computerised stratified randomisation to give approximately equal initial group mean body weights. - Observations and examinations performed and frequency:
- MORTALITY: Yes
- Time schedule: Throughout the study, all animals were checked early in each working day and again in the afternoon. At weekends and public holidays, a similar procedure were followed except that the final check was carried out at approximately mid-day.
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: All clinical signs were recorded for individual animals. Once before commencement of treatment and daily during the study, each animal was observed and any clinical signs was recorded. Observations were performed at the same time interval each day, the interval was selected taking into consideration the presence of post-dose reactions.
BODY WEIGHT: Yes
- Time schedule for examinations: Each animal was weighed on the day of allocation, twice weekly thereafter and on the day of necropsy.
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study):
- The weight of food consumed by each cage of rats was recorded at the same intervals as per body weight following allocation, where possible. The group mean daily intake per rat was calculated.
FOOD EFFICIENCY:
- Body weight gain in kg/food consumption in kg per unit time X 100 calculated as time-weighted averages from the consumption and body weight gain data: No
WATER CONSUMPTION AND COMPOUND INTAKE (if drinking water study): No
OPHTHALMOSCOPIC EXAMINATION: No
HAEMATOLOGY: Yes
- Time schedule for collection of blood: as part of sacrificial procedure
- Anaesthetic used for blood collection: Yes (isoflurane)
- Animals fasted: Yes
- How many animals: all viable animals
- Following parameters were examined: Haematocrit, Haemoglobin, Red blood cell count, Reticulocyte count, mean red blood cell volume, mean corpuscular haemoglobin, mean corpuscular haemoglobin concentration, white blood cell count, differential leucocyte count (Neutrophils, Lymphocytes, Eosinophils, Basophils, Monocytes, large unstained cells), Platelets
CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: as part of sacrificial procedure
- Animals fasted: Yes
- How many animals: all viable animals
- Following parameters were examined: Alkaline phosphatase, Alanine aminotransferase, Aspartate aminotransferase, Urea, Creatinine, Glucose, total bilirubin, total cholesterol, total protein, Sodium, Potassium, Calcium, Chloride, Bile Acids
PLASMA/SERUM HORMONES/LIPIDS: No
URINALYSIS: No
NEUROBEHAVIOURAL EXAMINATION: No
IMMUNOLOGY: No - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes (Adrenal glands, Liver, Kidneys, Spleen)
HISTOPATHOLOGY: No - Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- Sign of hairloss, from slight to moderate severity, was recorded in 3 out of 4 females at 1000 mg/kg/day (see table 1). No clinical signs were observed in males at both dose levels or in females at 300 mg/kg/day.
- Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- effects observed, non-treatment-related
- Description (incidence and severity):
- No treatment related changes were recorded. Males dosed at 1000mg/kg/day showed mean corpuscular haemoglobin concentration statistically significantly higher than controls (4%) and eosinophils statistically significantly lower than controls (46%). Changes were not consistent between sexes and were within the range of expected biological variation, therefore they were considered to be incidental.
- Clinical biochemistry findings:
- effects observed, non-treatment-related
- Description (incidence and severity):
- No treatment related changes were recorded. The statistically significant increase of calcium recorded in females dosed at 300 mg/kg/day (13%) was not dose related, therefore it was considered to be incidental.
- Endocrine findings:
- not examined
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Immunological findings:
- not examined
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Gross pathological findings:
- effects observed, treatment-related
- Description (incidence and severity):
- At post mortem evaluation treated males did not show treatment-related changes. Three out of 4 females receiving test item at 1000 mg/kg/day showed moderate hairloss mainly in the forelimbs, hindlimbs and thoracic region or in scapular region in females nos. Such findings could be considered treatment-related. The macroscopic changes noted in single females dosed at 300 mg/kg/day as single dark, depressed area - 2x1mm - in the glandular region of the stomach or unilateral (right) moderate pelvic dilatation in kidney were considered most likely stress related or incidental, respectively. Any other macroscopic observations were within the range of observed and expected incidental or spontaneous pathological changes in rats of the same age and considered unrelated to treatment.
- Neuropathological findings:
- not examined
- Histopathological findings: non-neoplastic:
- not examined
- Histopathological findings: neoplastic:
- not examined
- Other effects:
- not examined
- Dose descriptor:
- NOAEL
- Remarks on result:
- not determinable
- Remarks:
- no NOAEL identified
- Critical effects observed:
- not specified
- Conclusions:
- Based on the results, it can be concluded that dose levels up to 1000 mg/kg/day can be chosen for a subsequent reproductive toxicity study.
- Executive summary:
The aim of this preliminary study was to investigate toxic effects of the test substance when given at 300 and 1000 mg/kg/day for 2 consecutive weeks. The animals received the test item, or vehicle for the control rats, by oral gavage at the dose volume of 4 mL/kg. At completion of 2 week treatment period, no changes were seen in the body weight and food consumption throughout the study. No clinical signs were recorded with the exception of hairloss observed in females at 1000 mg/kg/day. No treatment-related changes were seen at clinical pathology examination. The necropsy confirmed the presence of hairloss area in females at 1000 mg/kg/day. No differences were found in the absolute or relative organ weights.
- Endpoint:
- sub-chronic toxicity: oral
- Type of information:
- experimental study planned (based on read-across)
- Justification for type of information:
- DISCLAIMER
This testing proposal to an analogue substance is based on the knowledge at the time of the dossier update submission. In reference to the testing strategy presented in section 13 of the dossier and in line with the dossier improvement pilot project (CEFIC, ECHA), the registrant upholds the option to reevaluate and change/adapt the strategy, the best suitable test substance, order and extent of studies performed to fulfill the registration requirements, as soon as new knowledge becomes available.
CATEGORY HYPOTHESIS
This read-across justification is based on the category approach. Seven substances are divided in two sub-groups with four substances in sub-group I and three substances in sub-group II. Members of the sub-group I are epoxidized fatty acid esters with free epoxy (EpO) groups (CAS 158318-67-3, CAS 97553-05-4, CAS 8013-07-8 and CAS 95370-96-0). Furthermore, data of CAS 8016-11-3 and CAS 61789-01-3 are used as supporting data. Members of the sub-group II are reaction products of epoxidized fatty acid esters with alcohol and contain reacted EpO groups (CAS 188831-96-1, CAS 211450-54-3 and CAS 85586-35-2). Data of the three substances CAS 96690-51-6, CAS 85586-34-1 and CAS 151661-88-0 are used as supporting data for sub-group II. Substances of both sub-groups are registered separately and are not yet part of a consortium.
This document covers physico-chemical properties, human toxicological parameters, environmental fate and pathways and ecotoxicological data. The read-across hypothesis is based on different compounds with qualitatively and quantitatively similar properties. No relevant variations in properties were observed and effects do not differ in strength among the category members (Read-Across Assessment Framework, RAAF, Scenario 6). Aforementioned chemicals can be included in two sub-groups for reasons presented subsequently.
All members and supporting substances of sub-group I and sub-group II are considered substances of Unknown or Variable composition, Complex reaction product or Biological material (UVCB). Therefore, no clearly definable structures and purities are described in this document. The constituents identified in these UVCBs are summarized in table 2.
Sub-group I:
All substances in this sub-group have a similar chemical structure (Epoxidized fatty acid esters) and have free EpO groups. They exhibit physico-chemical properties in a very comparable range. They are liquid at room temperature with similar melting and boiling points. Their water solubilities are in the same range and they have similar partition coefficients. Next to it, they have a high flash point and are not flammable, not explosive and without oxidizing properties.
Sub-group II:
All substances in this sub-group are reaction products of epoxidized fatty acid esters with alcohol and share a similar chemical structure with reacted EpO groups. Their physico-chemical properties are in a very comparable range and similar to the substances of sub-group I. They are also liquid at room temperature with similar melting and boiling points and have high flash points, are not flammable, not explosive and without oxidizing properties. The only difference is that they are only partially soluble in water and that their partition coefficient (log KOW) is lower.
This document shows that similar structures, physico-chemical properties and toxicokinetic potentials are predicted for all category members. Furthermore, nearly all substances of these two sub-groups do not possess any properties indicating a hazard for human health, environmental fate or ecotoxicity. The only exceptions are a precautionary classification of CAS 211450-54-3 and CAS 158318-67-3 as skin sensitizer Category 1B due to inconsistent data and a classification of CAS 188831-96-1 as reprotoxic Category 2 if the content of trimethylolpropane (TMP) is ≥ 3% because of reprotoxic properties of TMP.
This category approach is considered to be of great significance resulting in a decrease of the use of animal testing due to the redundancy of testing each individual substance for every endpoint. The overall data proved adequate to supporting hazard assessment. In addition, a greater body of data is available in comparison to using the analogue approach. Furthermore, the category approach is strengthened since all chemicals in the two sub-groups have a similar area of application. Detailed information on uses and manufacture can be obtained from corresponding Chemical Safety Report of category members. - Reason / purpose for cross-reference:
- other: testing strategy
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 408 (Repeated Dose 90-Day Oral Toxicity Study in Rodents)
- GLP compliance:
- yes
- Specific details on test material used for the study:
- 95370-96-0_Fatty acids, C14-22, 2ethylhexylesters, epoxidized
- Species:
- rat
- Route of administration:
- oral: unspecified
Referenceopen allclose all
Table 1: 2 WEEK PRELIMINARY ORAL TOXICITY STUDY IN RATS: Appearance of hairloss (Females)
Females | Control | 300 mg/kg/day | 1000 mg/kg/day | |||
a | b | a | b | a | b | |
Hairloss, Suprascapular, Bilateral, Moderate | 0 | 0 | 0 | 0 | 1 | 1.0 |
Hairloss, Suprascapular, Bilateral, Slight | 0 | 0 | 0 | 0 | 1 | 1.0 |
Hairloss, Thoracic, ventral, Moderate | 0 | 0 | 0 | 0 | 1 | 10.0 |
Hairloss, Upper forelimb, Slight | 0 | 0 | 0 | 0 | 2 | 2.0 |
Hairloss, Ventrum, Moderate | 0 | 0 | 0 | 0 | 1 | 1.0 |
a = Number of animals affected
b = Number of days with clinical sign/animal
Table 2:
Endpoint conclusion
- Endpoint conclusion:
- no study available (further information necessary)
- Dose descriptor:
- NOAEL
- Study duration:
- subacute
- Species:
- rat
Repeated dose toxicity: inhalation - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: inhalation - local effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - local effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
No studies on the test substance itself are available at the moment. An OECD 422 study is currently ongoing and a Repeated Dose 90-day oral toxicity study in rodents according to OECD 408 is proposed.
A 2 week oral toxicity dose range finding study has already been performed. The aim of this preliminary study was to investigate toxic effects of the test substance when given at 300 and 1000 mg/kg/day for 2 consecutive weeks. The animals received the test item, or vehicle for the control rats, by oral gavage at the dose volume of 4 mL/kg. At completion of 2 week treatment period, no changes were seen in the body weight and food consumption throughout the study. No clinical signs were recorded with the exception of hairloss observed in females at 1000 mg/kg/day. No treatment-related changes were seen at clinical pathology examination. The necropsy confirmed the presence of hairloss area in females at 1000 mg/kg/day. No differences were found in the absolute or relative organ weights.
Based on the results of this study, it can be concluded that dose levels up to 1000 mg/kg/day can be chosen for a subsequent reproductive toxicity study.
Justification for classification or non-classification
Currently no classification is possible due to missing data of the currently ongoing OECD 422 study.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.